Conestoga Capital Maintains National Research Corp. (NRC) Position Despite its Poor Returns Conestoga Capital Advisors, a boutique, independent investment management firm, published its fourth-quarter 2020 ‘Small Cap Growth & SMid Cap Growth’ Investor Letter – a copy of which can be downloaded here. A net return of 31% was recorded by Conestoga’s Small Cap Growth fund and 19.72% return by its SMid Cap Growth Fund for the the end year 2020. Both performed below their Russell 2000 Growth and Russell 2500 Growth benchmarks that delivered a 34.63% and 25.89% return respectively. You can view the fund’s top 5 holdings to have a peek at their top bets for 2021. Conestoga Capital Advisors, in their Q4 2020 investor letter, emphasized that National Research Corporation (NASDAQ: NRC) is among their Small Cap Growth Fund’s top 5 laggards. National Research Corporation is a Nebraska-based company that collects large volumes of healthcare consumer data, products and subscription-based solutions. It currently has a $1.3 billion market capitalization. In the past month, NRC is up 4.95%, extending its YTD gains to 23.44%. As of March 5, the stock closed at $52.77 per share.